Novartis Agrees to Acquire Avidity Biosciences for $12 Billion

0
Novartis Agrees to Acquire Avidity Biosciences for  Billion




The Swiss pharmaceutical company says the purchase would complement its existing pipeline of treatments for neuromuscle disorders.



Source link

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *